🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single centre, proof-of-concept phase I trial of atezolizumab in ...
Status
Active Not Recruiting
Location
Royal Marsden Hospital NHS Foundation Trust
Start Date
2018-08-13
Trial ID
NCT03673787
Treatments Being Tested
A study evaluating the safety, preliminary efficacy and pharmacokinetics of...
Status
Terminated
Location
HOPITAL JEAN MINJOZ; Oncologie
Start Date
2020-07-09
Trial ID
NCT04404140
Treatments Being Tested
This multicenter, international, Phase Ib/II trial consists of three stages...
Status
Completed
Location
HonorHealth Research Institute ? Bisgrove
Start Date
2012-01-11
Trial ID
NCT01485861
Treatments Being Tested
Analysis of circulating tumour DNA (ctDNA) found in a patient's peripheral ...
Status
Active Not Recruiting
Location
Addenbrookes Hospital
Start Date
2022-12-28
Trial ID
NCT04920708
Treatments Being Tested
This phase II trial compares the effect of adding ipatasertib to pembrolizu...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2022-07-26
Trial ID
NCT05172258
Treatments Being Tested
This ComboMATCH patient screening trial is the gateway to a coordinated set...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-07
Trial ID
NCT05564377
Treatments Being Tested
The purpose of this study is to find out whether a new drug, Ipatasertib, c...
Status
Active Not Recruiting
Location
Southern Highlands Cancer Centre
Start Date
2021-01-27
Trial ID
NCT04650581
Treatments Being Tested
This study will be a single center, open-label, 2-period, fixed-sequence, P...
Status
Completed
Location
Covance Research Unit - Dallas
Start Date
2017-07-18
Trial ID
NCT03222310
Treatments Being Tested
This study will evaluate the efficacy, safety, and pharmacokinetics of immu...
Status
Terminated
Location
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley
Start Date
2017-12-27
Trial ID
NCT03337698
This phase Ib/II trial tests the safety, side effects, best dose, and effec...
Status
Active Not Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-03-31
Trial ID
NCT05538897